Business Segments and Geographic Areas

12 Months Ended

Dec. 31, 2019

We are accounting and reporting for our business as a single operating segment entity engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. Our chief operating decision maker (the CEO) evaluates the various global product portfolios on a net sales basis and evaluates profitability, investment, cash flow metrics and allocates resources on a consolidated worldwide basis due to shared infrastructure and resources. Our product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures including 2DHD and 3DHD vision technologies and fees related to sales representation, promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, a line of cardiac monitoring products as well as electrosurgical generators and related instruments. These product lines' net sales and primary geographic market where the products are sold, are as follows for the years ended December 31, 2019, 2018 and 2017:



	2019
	Orthopedic Surgery		General Surgery		Total
Primary Geographic Markets
United States	$	179,419	$	337,246	$	516,665
Americas (excluding the United States)	64,269		31,004		95,273
Europe, Middle East & Africa	118,301		64,248		182,549
Asia Pacific	101,333		59,277		160,610
Total sales from contracts with customers	$	463,322	$	491,775	$	955,097



	2018
	Orthopedic Surgery		General Surgery		Total
Primary Geographic Markets
United States	$	172,462	$	276,186	$	448,648
Americas (excluding the United States)	66,519		31,009		97,528
Europe, Middle East & Africa	112,998		53,565		166,563
Asia Pacific	94,749		52,146		146,895
Total sales from contracts with customers	$	446,728	$	412,906	$	859,634



	2017
	Orthopedic Surgery		General Surgery		Total
Primary Geographic Markets
United States	$	167,602	$	243,439	$	411,041
Americas (excluding the United States)	60,439		30,730		91,169
Europe, Middle East & Africa	106,921		48,928		155,849
Asia Pacific	93,982		44,351		138,333
Total sales from contracts with customers	$	428,944	$	367,448	$	796,392

Sales are attributed to countries based on the location of the customer. There were no significant investments in long-lived assets located outside the United States at December 31, 2019 and 2018. No single customer represented over 10% of our consolidated net sales for the years ended December 31, 2019, 2018 and 2017.